Merve YEDİYILDIZ BULUN, RESUL YILMAZ, Osman Mücahit TOSUN, RUHİYE REİSLİ, SEMA TUNCER UZUN

CANAVAN HASTALIĞINDA ANESTEZİ YÖNETİMİ: İKİ OLGU SUNUMU

Canavan hastalığı, aspartoaçilaz enzim eksikliği ile karakterize, otozomal resesif kalıtılan ilerleyici bir lökodisitrofidir. Canavanhastalığında makrosefali, kas güçsüzlüğü, yutma bozukluğu, gastroözefageal reflü ve epilepsi görülebilecek bulgulardandır. Tedavisisemptomatiktir. Bu yazıda Canavan hastalığı olan iki olguda uyguladığımız anestezi deneyiminin tartışılması amaçlanmıştır

ANESTHESIA MANAGEMENT IN CANAVAN DISEASE: TWO CASE REPORTS

Canavan disease is an autosomal recessive, progressive leucodistrophy characterized by aspartoacylase enzyme deficiency.Macrocephaly, muscle weakness, swallowing disorder, gastroesophageal reflux and epilepsy can be seen in Canavan disease.Treatment is symptomatic. In this article we aimed to discuss the anesthesia experience that we have performed in two Canavandisease cases

PDF

___

1. Baum VC, O’Flaerty JE. Anaesthesia for genetic, metabolic and dismorphic syndromes of childhood. Phliadelphia, USA. Lippincott Williams&Wilkins 2nd ed. 2007; 59.
2. Elpeleg ON, Anikster Y, Barash V, Branski D, Shaag A. The frequency of the C854 mutation in the aspartoacylase gene in Ashkenazi Jews in Israel. Am J Hum Fenet 1994; 55: 287-288.
3. Matalon R, Michals-Matalon K. Canavan Disease Synonyms: ASPA Deficiency, Aspartoacylase Deficiency, Initial Posting; 1999; Last Update: August 11, 2011.
4. Matalon R, Matalon KM. Canavan disease pre-natal diagnosis and genetic counseling. Obstet Gynecol Clin North Am 2002; 29: 297-304.
5. Michaelis R, Niemann G. Makro und mikrosefa-li In. Entwicklungsneurologie und Neuropädiatrie. Thieme. 2. Aufl. Stutgart 1999: 139-155.
6. Tobias JD. Anaesthetic considerations for the child with leukodystrophy. Can J Anaesth 1992; 39: 394-397.
7. Kafadar ‹, Tufan Tafl B, Ayd›n K›l›ç B. Huzursuzluk ve bafl tutamama yak›nmas› ile baflvuran hastada nadir bir lökodistrofi nedeni: Canavan Hastal›¤›: Olgu sunumu. JOPP Derg 2012; 4: 138-143.
8. Kafadar ‹, Tufan Tafl B, Ayd›n K›l›ç B. Huzursuzluk ve bafl tutamama yak›nmas› ile baflvuran hastada nadir bir lökodistrofi nedeni: Canavan Hastal›¤›: Olgu sunumu. JOPP Derg 2012; 4: 138-143.
9. Harding BN, Surtees R. Metabolic and neurode-generative diseases of childhood. In Graham DI, Lantos PL eds. Greenfield’s Neuropathology vol1, 7th ed. London: Arnold; 2002: 485-511.
10. Ellison D, Love S, Harding BN, Lowe J. Vinters HV eds. Disorders that primarily affect white matter. Neuropathology, 2nd ed. London, Mosby; 2004: 119-129.
11. Al-Dirbashi OY, Kurdi W, Imtiaz F ve ark. Reliable prenatal diagnosis of Canavan disea-se by measuring N-acetylaspartate in amniotic fluid using liquid chromatography tandem mass spectrometry. Prenat Diagn 2009; 29: 477-480.
12. Topçu M, Yalnizo¤lu D, Saatçi I, Halilo¤lu G ve ark. Effect of topiramate on enlargement of head in Canavan disease: a new option for treatment of megalen-cephaly. Turk J Pediatr 2004; 46: 67-71.
13. Karacalar S, Kaynar A, Kelsaka E, Sar›hasan B. Kanavan hastal›¤›nda anestezik yaklafl›m›m›z. Türk Anest Rean Der Dergisi 2008; 36: 134-136.